miRNA-21 also acts on ovarian cancer via the PI3K/AKT/mTOR pathway by suppressing PTEN, and is even activated by AKT in hypoxic conditions to induce survival [65,66]. This evidence concerns the gene PIK3CB and ovarian cancer.